Azienda Usl Reggio Emilia - Irccs
Clinical trials sponsored by Azienda Usl Reggio Emilia - Irccs, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Silent suffering: new tool could help spot hip pain in kids who Can't speak Results expected Dec 2026 (estimated)
- New study hopes to predict hodgkin lymphoma outcomes better Results expected Dec 2026 (estimated)
- Parkinson's gene mutation may raise cancer risk – large study investigates Results expected Dec 2026 (estimated)
- Study questions best surgery for High-Risk endometrial cancer Results expected Dec 2026 (estimated)
- Could a lifesaving leukemia drug harm Men's sexual health? Results expected Dec 2026 (estimated)
-
Italian study examines targeted radiation for rare gland tumors
Disease control Not yet recruitingThis study looks back at how well a type of targeted radiation therapy (PRRT) works for people with advanced pheochromocytoma and paraganglioma, rare tumors of the adrenal glands. Researchers will analyze data from about 210 patients treated in Italy over 24 years. The goal is to…
Sponsor: Azienda USL Reggio Emilia - IRCCS • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Can meditation reduce burnout for cancer care staff? new trial aims to find out
Symptom relief Not yet recruitingThis study tests a 7-week mindfulness and compassion program (MCCP) for doctors, nurses, and nursing assistants who care for cancer patients. The goal is to see if it boosts positive emotions and reduces negative feelings like stress and burnout. 160 participants will be randomly…
Sponsor: Azienda USL Reggio Emilia - IRCCS • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC